Molecular cloning and characterisation of the human anaphylatoxin C3a receptor, J. Biol. Chem, vol.271, pp.20231-20234, 1996. ,
Absence of induction of IL-1 production in human monocytes by complement fragments, J. Immunol, vol.142, pp.173-178, 1989. ,
Interleukin-3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a, Proc. Natl. Acad. Sci. USA, vol.87, pp.6813-6817, 1990. ,
Identification of a common nucleotide sequence in the 3-untranslated region of mRNA molecules specifying inflammatory mediators, Proc. Natl. Acad. Sci. USA, vol.83, pp.1670-1674, 1986. ,
Immunocytochemical localisation of the terminal complement complex in multiple sclerosis, Neuropathol. Appl. Neurobiol, vol.15, pp.307-316, 1989. ,
Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U937 cells, Eur. J. Immunol, vol.26, pp.1944-1950, 1996. ,
C5a-induced expression of P-selectin in endothelial cells, J. Clin. Invest, vol.94, pp.1147-1150, 1994. ,
Complement interactions and functions: the role of complement in inflammation and phagocytosis, Immunol. Today, vol.12, pp.322-326, 1991. ,
Interleukin-6 (IL-6), a molecule with both beneficial and destructive potentials, Prog. Neurobiol, vol.52, pp.379-390, 1997. ,
Expression of complement components of the alternative pathway by glioma cell lines, J. Immunol, vol.149, pp.1381-1387, 1992. ,
Expression of the complement classical pathway by human glioma in culture. A model for complement expression by nerve cells, J. Biol. Chem, vol.268, pp.25068-25074, 1993. ,
Identification and characterisation of the complement C5a anaphylatoxin receptor on human astrocytes: relevance to inflammation in the brain, J. Immunol, vol.155, pp.4882-4889, 1995. ,
Complement expression in human brain. Biosynthesis of terminal pathway components and regulators in human glial cells and cell lines, J. Immunol, vol.154, pp.4726-4733, 1995. ,
The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis, J. Immunol, vol.160, pp.3543-3554, 1998. ,
The chemotactic receptor for C5a anaphylatoxin, Nature, vol.349, pp.614-617, 1991. ,
Induction of interleukin-1 secretion and enhancement of humoral immunity by binding of human C5a to macrophages surface C5a receptors, J. Exp. Med, vol.156, pp.912-917, 1982. ,
C3a (C3adesarg) induces production and release of interleukin-1 by cultured human monocytes, J. Immunol, vol.139, pp.794-799, 1987. ,
Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung, J. Immunol, vol.154, pp.1861-1869, 1995. ,
Expression of a functional anaphylatoxin C3a receptor by astrocytes, J. Neurochem, vol.71, pp.2487-2496, 1998. ,
Complement mRNAs in the mammalian brain: responses to Alzheimer's disease and experimental brain lesioning, Neurobiol. Aging, vol.13, pp.641-648, 1992. ,
Peripheral blood mononuclear cells stimulated with C5a or lipopolysaccharide to synthesize equivalent levels of IL-1 mRNA show unequal IL-1 protein accumulation but similar polyribosome profiles, J. Immunol, vol.153, pp.277-286, 1994. ,
The role of complement in the pathogenesis of experimental allergic encephalomyelitis, Brain, vol.112, pp.895-911, 1989. ,
, , 1994.
, Hypoxia/reoxygenation-mediated induction of astrocyte interleukin-6: a paracrine mechanism potentially enhancing neuron survival, J. Exp. Med, vol.180, pp.2297-2308
IL-6 detection in multiple sclerosis brain, J. Neurol. Sci, vol.146, pp.59-65, 1996. ,
Identification of an AUUUA-specific messenger RNA binding protein, Science, vol.246, pp.664-668, 1989. ,
Inflammatory cytokines in the CNS. Possible role in the pathogenesis of neurodegenerative disorders and therapeutic implications, Pharmacol. Pathophysiol, vol.3, pp.214-228, 1997. ,
Complement fragment C3a stimulates Ca 2 influx in neutrophils via a pertussis-toxin sensitive G protein, Eur. J. Biochem, vol.217, pp.289-294, 1993. ,
Complement C1q and C4 mRNA responses to lesioning in rat brain, Exp. Neurol, vol.118, pp.117-125, 1992. ,
Killing rat glial cells by complement components: deficiency of the rat analogue CD59 is the cause of oligodendrocyte susceptibility to lysis, J. Neuroimmunol, vol.48, pp.169-176, 1993. ,
Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis, J. Immunol, vol.152, pp.5477-5484, 1994. ,
Complement activation by -amyloid in Alzheimer disease, Proc. Natl. Acad. Sci. USA, vol.89, pp.10016-10020, 1992. ,
cDNA cloning of a novel G-protein-coupled receptor with a large extracellular loop structure, Biochim. Biophys. Acta, vol.1305, pp.39-43, 1996. ,
Purification of the active C5a receptor from human polymorphonuclear leukocytes as a receptor-G i complex, Proc. Natl. Acad. Sci. USA, vol.88, pp.971-975, 1991. ,
, mRNA INDUCTION BY ANAPHYLATOXINS ON ASTROCYTES, vol.72, issue.6, pp.2435-2441, 1999.
Molecular Cloning, A Laboratory Manual, vol.22, pp.7-19, 1989. ,
Characterisation of rat C5a anaphylatoxin receptor (C5aR): cloning of rat C5aR cDNA and study of C5aR expression by rat astrocytes, Mol. Brain Res, vol.48, pp.215-222, 1997. ,
C3a and C5a anaphylatoxin receptors, Med. Sci, vol.14, pp.291-299, 1998. ,
Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: translational signal provided by lipopolysaccharide or IL-1, Blood, vol.76, pp.1631-1638, 1990. ,
A new biological role for C3a and C3a desarg. Regulation of TNF-and IL-1 synthesis, J. Immunol, vol.156, pp.3455-3460, 1996. ,
Deletion of the 3-untranslated region of human BSF-2 mRNA causes stabilisation of the mRNA and high-level expression in mouse NIH-3T3 cells, Biochem. Biophys. Res. Commun, vol.163, pp.1056-1062, 1989. ,
Complement gene expression in human brain: comparison between normal and Alzheimer disease cases, Mol. Brain Res, vol.14, pp.109-116, 1992. ,
CD88 antibodies specifically bind to C5aR on dermal CD117 and CD14 cells and react with a desmosomal antigen in human skin, J. Immunol, vol.157, pp.1729-1735, 1996. ,
Oligodendrocytes and oligodendrocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody, Proc. Natl. Acad. Sci. USA, vol.86, pp.9025-9029, 1989. ,